| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8303987787779df93a157043542aa53e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9eed4c910214b614d1a7555983eff058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_214a392d957d4208bceb901507e4f110
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31fef0ddf27e9f67a7159907309a20e5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 |
| filingDate |
2020-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cae61438b2b14a6127b273adea35f79d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4777ff5b96bbb998465a9f7d5160c75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eced95dc1d968d3d71d9cf479bbec8ee |
| publicationDate |
2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
IL-274445-A |
| titleOfInvention |
Adenosine pathway inhibitors for cancer treatment |
| priorityDate |
2017-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |